Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 145
Filter
1.
Langmuir ; 31(19): 5440-8, 2015 May 19.
Article in English | MEDLINE | ID: mdl-25915504

ABSTRACT

Exosome size distributions and numbers of exosomes released per cell are measured by asymmetric flow-field flow fractionation/multi-angle light scattering (A4F/MALS) for three thyroid cancer cell lines as a function of a treatment that inhibits MAPK signaling pathways in the cells. We show that these cell lines release exosomes with well-defined morphological features and size distributions that reflect a common biological process for their formation and release into the extracellular environment. We find that those cell lines with constitutive activation of the MAPK signaling pathway display MEK-dependent exosome release characterized by increased numbers of exosomes released per cell. Analysis of the measured exosome size distributions based on a generalized extreme value distribution model for exosome formation in intracellular multivesicular bodies highlights the importance of this experimental observable for delineating different mechanisms of vesicle formation and predicting how changes in exosome release can be modified by pathway inhibitors in a cell context-dependent manner.


Subject(s)
Exosomes/metabolism , MAP Kinase Kinase Kinases/antagonists & inhibitors , MAP Kinase Signaling System/drug effects , Fractionation, Field Flow , Humans , MAP Kinase Kinase Kinases/metabolism , Scattering, Radiation , Tumor Cells, Cultured
2.
Inflammopharmacology ; 21(2): 129-36, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23242572

ABSTRACT

Curcuma longa Linn. is widely used for the treatment of disorders associated with inflammation and was evaluated for its safety and efficacy in the treatment of painful knee osteoarthritis (OA). This was a randomized, single blind, placebo-controlled trial. Total of 120 patients (37 males and 83 females) with primary knee OA received either placebo (400 mg twice daily) or NR-INF-02 (500 mg twice daily) or glucosamine sulphate (GS) (750 mg twice daily) alone or combination of NR-INF-02 and GS for 42 days. The efficacy was assessed during treatment period, on day 21 and day 42. The decrease in severity of pain symptom and function of affected knee as primary efficacy outcome measure was assessed by Visual Analog Scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scale, respectively. The clinical examination of affected joint was measured by an orthopaedic specialist and using a Clinician Global Impression Change (CGIC) scale. The analysis of post-treatment scores following administration of NR-INF-02 using VAS, WOMAC, and CGIC at each clinical visit showed significant decrease (p < 0.05) compared to placebo. NR-INF-02 treated group showed a significant (p < 0.01) decrease in use of rescue medication, along with clinical and subjective improvement compared to placebo. The tolerability and acceptability profile of NR-INF-02 was better during the trial period. The study demonstrates safety and efficacy of NR-INF-02 as a useful treatment option for patients with primary painful knee OA.


Subject(s)
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Curcuma/chemistry , Osteoarthritis, Knee/drug therapy , Pain/drug therapy , Plant Extracts/therapeutic use , Female , Glucosamine/therapeutic use , Humans , Knee Joint/drug effects , Male , Middle Aged , Osteoarthritis, Knee/complications , Pain/etiology , Pain Measurement/drug effects , Pain Measurement/methods , Severity of Illness Index , Single-Blind Method , Treatment Outcome
3.
J Pharmacol Pharmacother ; 3(1): 48-54, 2012 Jan.
Article in English | MEDLINE | ID: mdl-22368417

ABSTRACT

OBJECTIVES: To compare the safety and efficacy of glucosamine HCl- sustained release (GLU-SR) with that of Glucosamine HCl- immediate release (GLU-IR) in patients with knee osteoarthritis (OA). MATERIALS AND METHODS: This study involved 59 patients with knee OA, randomised to receive single oral dose of 1,500 mg, GLU-SR and GLU-IR for 60 days with 31 and 28 patients, respectively. The primary efficacy (pain and function) was assessed using visual analogue scale (VAS) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) scores. Intention-to-treat principle, repeated measure of ANOVA and mixed model analysis were used. RESULTS: The patients baseline, demographic and clinical characteristics were comparable between groups with female preponderance (71.20%). There was a significant reduction in algofunctional indices as primary outcome measure in both the groups across time (P < 0.001) and 29% lesser adverse events (AEs) in GLU-SR group, with no difference in the use of rescue medications. CONCLUSIONS: The study showed equal efficacy of the glucosamine formulations on algofunctional indices in reducing pain in patients with knee OA with less number of AEs in GLU-SR.

4.
Oncogene ; 30(42): 4307-15, 2011 Oct 20.
Article in English | MEDLINE | ID: mdl-21532616

ABSTRACT

Akt activation is common in progressive thyroid cancer. In breast cancer, Akt1 induces primary cancer growth, but is reported to inhibit metastasis in vivo in several model systems. In contrast, clinical and in vitro studies suggest a metastasis-promoting role for Akt1 in thyroid cancer. The goal of this study was to determine the functional role of Akt1 in thyroid cancer growth and metastatic progression in vivo using thyroid hormone receptor (TR) ß(PV/PV) knock-in (PV) mice, which develop metastatic thyroid cancer. We crossed Akt1(-/-) and PV mice and compared tumor development, local progression, metastasis and histology in TRß(PV/PV)/Akt1(+/+) (PVPV-Akt1WT) and TRß(PV/PV)/Akt1(-/-) (PVPV-Akt1KO) mice. Mice were killed at 3, 6, 9, 12 and 15 months; necropsy was performed and serum thyroid stimulating hormone (TSH) was measured. Thyroid hyperplasia occurred in both groups beginning at 3 months; the thyroid size was greater in the PVPV-Akt1WT mice (P<0.001). In comparison with PVPV-Akt1WT mice, thyroid cancer development was delayed in the PVPV-Akt1KO mice (P=0.003) and the degree of tumor invasiveness was reduced. The PVPV-Akt1WT mice displayed pulmonary metastases at 12 and 15 months of age, by contrast PVPV-Akt1KO mice did not develop distant metastases at 15 months of age. Despite continued expression of Akt2 or Akt3, pAkt levels were decreased and there was evidence of reduced Akt effect on p27 in the PVPV-Akt1KO thyroids. TSH levels were similarly elevated in PV mice regardless of Akt1 expression. In conclusion, thyroid cancer development and progression in TR ß(PV/PV) mice are Akt1-dependent, consistent with a tumor progression-promoting role in this murine thyroid cancer model.


Subject(s)
Adenoma/enzymology , Carcinoma/enzymology , Neovascularization, Pathologic/enzymology , Proto-Oncogene Proteins c-akt/deficiency , Thyroid Neoplasms/enzymology , Adenoma/blood supply , Animals , Carcinoma/blood supply , Carcinoma/secondary , Gene Knock-In Techniques , Lung Neoplasms/secondary , Mice , Mice, Inbred C57BL , Proto-Oncogene Proteins c-akt/metabolism , Thyroid Neoplasms/blood supply , Thyroid Neoplasms/pathology , Thyrotropin/blood
5.
Arch Environ Contam Toxicol ; 58(4): 1065-73, 2010 May.
Article in English | MEDLINE | ID: mdl-19937321

ABSTRACT

Neurotoxicity is one of the major effects of tributyltin (TBT). The effects on the next generation of F(1) rats exposed to TBT via the placenta and their dams' milk may be stronger than those on adults. Pregnant Wister rats were exposed to TBT at 0 and 125 ppm in their food. Half of the female F(1) rats in both groups were exposed to TBT at 125 ppm in their food from 9 to 15 weeks of age. Female F(1) rats were divided into the following groups: the control-control (CC) group, with no exposure; the TBT-control (TC) group, exposed to TBT via the placenta and their dams' milk; the control-TBT (CT) group, exposed to TBT via their food from 9 to 15 weeks of age; and the TBT-TBT (TT) group, exposed to TBT via the placenta, their dams' milk, and their food (n = 10/group). After administration, an open-field test and prepulse inhibition (PPI) test were performed at 15 weeks of age. The mean body weights of the TC and TT groups were significantly lower than that of the CC group from 9 to 15 weeks of age. The mean relative thymus weight of the TC and TT groups was significantly lower than that of the CC group. In the open-field test, a marked decrease in the total locomotion distance was observed in the TT group. The mean values in the TT and TC groups were significantly lower than that in the CC group. For the locomotion distance between 15 and 20 min, the mean values in the CT, TC, and TT groups were significantly lower than that in the CC group. The mean locomotor distance between 25 and 30 min in the TT group was significantly lower than that in the CC and TC groups. The mean values of instances of wall rearing in the TC, CT, and TT groups were significantly lower than that in the CC group. The mean value of face washing or body washing in the TT group was significantly lower than that in the CT group. There were no significant differences in indexes of the PPI test. Exposure to TBT via the placenta and their dams' milk inhibited the development of F(1) rats, which continued after weaning. Inhibition of the rats' activity induced by exposure to TBT via the placenta and their dams' milk and/or via their food was suggested. The effects were most evident in the TT group.


Subject(s)
Behavior, Animal/drug effects , Environmental Pollutants/toxicity , Maternal Exposure/adverse effects , Motor Activity/drug effects , Prenatal Exposure Delayed Effects/chemically induced , Trialkyltin Compounds/toxicity , Animals , Body Weight/drug effects , Female , Organ Size/drug effects , Pregnancy , Prenatal Exposure Delayed Effects/physiopathology , Prenatal Exposure Delayed Effects/psychology , Rats , Rats, Wistar
6.
Neuroscience ; 159(1): 127-35, 2009 Mar 03.
Article in English | MEDLINE | ID: mdl-19010396

ABSTRACT

Activation of N-methyl-d-aspartic acid (NMDA) glutamate receptors (NMDARs) is required for long-term potentiation (LTP) of excitatory synaptic transmission at hippocampal CA1 synapses, the proposed cellular mechanisms of learning and memory. We demonstrate here that a brief bath co-application of a low concentration of NMDA, an agonist of NMDARs, and the selective antagonist of NR2B-containing NMDARs, (alpha R, beta S)-alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidinepropanol (Ro25-6981), to hippocampal slices from young adult rats produced a slowly developing LTP persisting at least for 6 h following a transient depression of synaptic transmission in CA1 synapses. The LTP was likely to occur at postsynaptic site and was initiated by activation of NMDARs, and its development was mediated by cAMP-dependent protein kinase (PKA) activation and protein synthesis. This chemically induced LTP and the tetanus-induced late phase of LTP (L-LTP) were mutually occluding, suggesting a common expression mechanism. Thus, we have demonstrated that a brief bath co-application of NMDA with Ro25-6981 to a slice offers an alternative to electrical stimulation as a stimulation method to induce L-LTP. The chemically induced LTP did not require the low-frequency test stimulation typically used to monitor the strength of synapses during and after drug application. Thus, the LTP may occur at a large fraction of synapses in the slice and not to be confined to a small fraction of the synapses where electrical stimulation can reach and induce LTP. Therefore, this chemically induced LTP may be useful for assessing the biochemical and morphological correlates and the molecular aspects of the expression mechanism for L-LTP that has been proven to correlate to hippocampal long-term memory.


Subject(s)
Excitatory Amino Acid Agonists/pharmacology , Hippocampus/drug effects , Long-Term Potentiation/drug effects , N-Methylaspartate/pharmacology , Phenols/pharmacology , Piperidines/pharmacology , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Analysis of Variance , Animals , Biophysics , Drug Combinations , Electric Stimulation/methods , Excitatory Amino Acid Antagonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , In Vitro Techniques , Male , Rats , Rats, Wistar
7.
J Endocrinol ; 189(3): 605-15, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16731791

ABSTRACT

Increased major histocompatibility complex (MHC) class I gene expression in nonimmune cell 'target tissues' involved in organ-specific diseases may be important in the pathogenesis of autoimmune diseases. This possibility in part evolves from studies of cultured thyrocytes where properties appear relevant to the development of thyroid autoimmune disease. In FRTL-5 rat thyroid cells in continuous culture, hormones and growth factors that regulate cell growth and function specifically decrease MHC class I gene expression. We hypothesized that this could reflect a mechanism to preserve self-tolerance and prevent autoimmune disease. The mechanisms of action of some of these hormones, namely TSH and hydrocortisone, have been already characterized. In this report, we show that IGF-I transcriptionally downregulates MHC class I gene expression and that its action is similar to that of insulin. The two hormones have a complex effect on the promoter of the MHC class I gene, PD1. In fact, they decrease the full promoter activity, but upregulate the activity of deleted mutants that have lost an upstream, tissue-specific regulatory region but still retain the enhancer A region. We show that insulin/IGF-I promotes the interactions of the p50/p65 subunits of NF-kappaB and AP-1 family members with these two regions, and that the tissue-specific region acts as a dominant silencer element on insulin/IGF-I regulation of promoter activity. These observations may be important to understand how MHC class I gene transcription is regulated in the cells.


Subject(s)
Gene Expression Regulation/drug effects , Genes, MHC Class I , Insulin-Like Growth Factor I/pharmacology , Insulin/pharmacology , Thyroid Gland/metabolism , Transcription, Genetic , Animals , Cell Line , Electrophoretic Mobility Shift Assay , Enhancer Elements, Genetic , Flow Cytometry , Fluorescent Antibody Technique , NF-kappa B/genetics , Promoter Regions, Genetic , Rats , Thyroid Gland/drug effects , Transcription Factor AP-1/genetics
8.
J Orthop Surg (Hong Kong) ; 13(3): 310-3, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16365499

ABSTRACT

Carpal dislocation and fracture dislocation are uncommon and difficult to treat. Early diagnosis and treatment of such injuries are necessary to prevent progressive carpal instability and traumatic arthritis. Perilunate fracture dislocation is a combination of ligamentous and osseous injuries that involve the 'greater arc' of the perilunate. Despite being severe, these injuries often go unrecognised in the emergency department, leading to delayed diagnosis and treatment. We present a case of greater arc injury of the right wrist with fractures of the lunate and ulnar styloid without perilunate dislocation. This pattern of injury cannot be classified in the available literature on greater arc injury.


Subject(s)
Fracture Fixation, Internal/methods , Fractures, Bone/surgery , Joint Dislocations/surgery , Lunate Bone/injuries , Wrist Injuries/surgery , Adult , Fractures, Bone/diagnostic imaging , Humans , Joint Dislocations/diagnostic imaging , Male , Tomography, X-Ray Computed , Wrist Injuries/diagnostic imaging
9.
J Neuroendocrinol ; 17(12): 836-45, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16280031

ABSTRACT

The mechanism by which a lack of thyroid hormone in the early development of the brain causes permanent mental retardation in cretins is currently unknown. On the other hand, an abnormality in dopamine-related brain function is believed to underlie some forms of mental illness. In this study, we demonstrate that although the activation of a dopaminergic D(2)-like receptor inhibited glutamatergic transmission in the hippocampal slices of normal adult rats, indicating the inhibitory action of the D(2)-like receptor on glutamatergic transmission, it markedly enhanced glutamatergic transmission both in a mutant hypothyroid rat with a missense mutation in thyroglobulin and in hypothyroid rats treated with methylmercaptoimidazole (MMI), indicating the excitatory action of the D(2)-like receptor on glutamatergic transmission. Paired pulse facilitation of field excitatory postsynaptic potentials was reduced by the activation of the D(2)-like receptors from MMI-induced hypothyroid rats, suggesting a presynaptic locus of the excitatory action of the D(2)-like receptors. In normal rats, the excitatory D(2)-like dopamine receptors were observed in the developing stages and were completely replaced by normal inhibitory responses up to adulthood. Furthermore, the continuous supplement of thyroxine from birth exerted a normalising effect on the abnormal excitatory property of D(2)-like dopamine receptors in the hippocampal slices of MMI-treated hypothyroid rats. From these results, it is suggested that thyroxine may play a crucial role in reversing the excitatory property of D(2)-like dopaminergic receptors in the immature brain to an inhibitory one in the mature brain. Moreover, we suggest that the abnormal excitatory property of D(2)-like dopaminergic receptors may develop in response to a lack of thyroxine and may contribute to some central nervous system deficits, including cognitive dysfunctions accompanied by hypothyroidism.


Subject(s)
Congenital Hypothyroidism/physiopathology , Hippocampus/growth & development , Hippocampus/physiology , Neural Inhibition/physiology , Receptors, Dopamine D2/physiology , Thyroxine/physiology , Animals , Congenital Hypothyroidism/drug therapy , Dopamine Agonists/pharmacology , Excitatory Postsynaptic Potentials/drug effects , Excitatory Postsynaptic Potentials/physiology , Hippocampus/drug effects , Male , Mutation, Missense , Organ Culture Techniques , Quinpirole/pharmacology , Rats , Rats, Mutant Strains , Rats, Wistar , Receptors, Dopamine D1/physiology , Thyroglobulin/genetics , Thyroxine/pharmacology
10.
J Orthop Surg (Hong Kong) ; 13(2): 211-3, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16131691

ABSTRACT

Enthesopathy at the superior or inferior surface of a calcaneus may be seen in normal individuals having degenerative osteoarthrosis. This condition is also known to occur in patients with rheumatoid arthritis, seronegative spondyloarthropathy, trauma, as well as inflammatory and metabolic diseases. Enthesopathy may sometimes be the first manifestation of a variety of rheumatic diseases. In this report, we present a case of massive enthesopathy of the superior and inferior surface of the calcaneus giving rise to an 'axe effect'.


Subject(s)
Calcaneus/pathology , Leg Ulcer/diagnosis , Rheumatic Diseases/diagnosis , Aged , Aged, 80 and over , Calcaneus/diagnostic imaging , Chronic Disease , Follow-Up Studies , Humans , Leg Ulcer/complications , Male , Radiography , Rheumatic Diseases/complications , Risk Assessment , Severity of Illness Index , Wound Healing/physiology
11.
Endocr Relat Cancer ; 12(1): 173-83, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15788648

ABSTRACT

Like children exposed to Chernobyl fallout, the workers who cleaned up after the accident, also known as liquidators, have exhibited an increased incidence of thyroid cancer. A high prevalence of ret/PTC3 rearrangement has been found in pediatric post-Chernobyl thyroid tumors, but this feature has not been investigated in liquidator thyroid tumors. In this study we analyzed the prevalence of ret/PTC1 and ret/PTC3 in thyroid tumors from 21 liquidators, 31 nonirradiated adult Ukrainian patients, and 34 nonirradiated adult French patients. ret rearrangements in carcinomas were found in 83.3% of liquidators, 64.7% of Ukrainian patients, and 42.9% of French patients. The prevalence of ret/PTC1 was statistically similar in the three groups. The prevalence of ret/PTC3 was significantly higher in liquidators than in French patients (P = 0.03) but it was also high in nonirradiated Ukrainian patients who exhibited values intermediate between liquidators and French patients. In adenomas the prevalence of rearrangement was significantly higher in all Ukrainians than in French patients (P = 0.004). Like children exposed to Chernobyl fallout, liquidators showed a high prevalence of ret/PTC3. This finding suggests that irradiation had the same effect regardless of age. However, given the high rate of ret/PTC3 in nonirradiated adult Ukrainians, the possibility of genetic susceptibility or low-level exposure to radiation in that group cannot be excluded.


Subject(s)
Carcinoma, Papillary/etiology , Neoplasms, Radiation-Induced/etiology , Oncogene Proteins/genetics , Radioactive Hazard Release , Thyroid Neoplasms/etiology , Transcription Factors/genetics , Adult , Aged , Carcinoma, Papillary/epidemiology , Child , France/epidemiology , Gene Rearrangement , Humans , Middle Aged , Neoplasms, Radiation-Induced/epidemiology , Nuclear Receptor Coactivators , Oncogene Proteins, Fusion , Protein-Tyrosine Kinases , Thyroid Neoplasms/epidemiology , Ukraine/epidemiology
12.
J Med Genet ; 41(3): 161-70, 2004 Mar.
Article in English | MEDLINE | ID: mdl-14985374

ABSTRACT

INTRODUCTION: Akt activation is involved in the pathogenesis of inherited thyroid cancer in Cowden's syndrome and in sporadic thyroid cancers. In cell culture, Akt regulates thyroid cell growth and survival; but recent data suggest that Akt also regulates cell motility in non-thyroid cell lines. We therefore sought to evaluate the role of Akt in thyroid cancer progression. METHODS: We evaluated 46 thyroid cancer, 20 thyroid follicular adenoma, and adjacent normal tissues samples by immunohistochemistry for activated Akt (pAkt), Akt 1, 2, and 3, and p27 expression. Immunoblots were performed in 14 samples. RESULTS: Akt activation was identified in 10/10 follicular cancers, 26/26 papillary cancers, and 2/10 follicular variant of papillary cancers, but in only 4/66 normal tissue samples and 2/10 typical benign follicular adenomas. Immunoactive pAkt was greatest in regions of capsular invasion; and was localised to the nucleus in follicular cancers and the cytoplasm in papillary cancers, except for invasive regions of papillary cancers where it localised to both compartments. Immunoactive Akt 1, but not Akt 2 or Akt 3, correlated with pAkt localisation, and nuclear pAkt was associated with cytoplasmic expression of p27. In vitro studies using human thyroid cancer cells demonstrated that nuclear translocation of Akt 1 and pAkt were associated with cytoplasmic p27 and cell invasion and migration. Cell migration and the localisation of Akt 1, pAkt, and p27 were inhibited by PI3 kinase, but not MEK inhibition. DISCUSSION: These data suggest an important role for nuclear activation of Akt 1 in thyroid cancer progression.


Subject(s)
Proto-Oncogene Proteins , Retroviridae Proteins, Oncogenic/metabolism , Thyroid Neoplasms/enzymology , Thyroid Neoplasms/pathology , Adenoma/enzymology , Adenoma/genetics , Adenoma/pathology , Cell Cycle Proteins/metabolism , Cell Movement , Cell Nucleus/enzymology , Cell Nucleus/metabolism , Cyclin-Dependent Kinase Inhibitor p27 , Cytoplasm/enzymology , Disease Progression , Enzyme Activation , Humans , Immunohistochemistry , Isoenzymes/metabolism , Neoplasm Invasiveness , Oncogene Protein v-akt , Phosphatidylinositol 3-Kinases/metabolism , Protein Serine-Threonine Kinases/metabolism , Protein Transport , Proto-Oncogene Proteins c-akt , Thyroid Gland/cytology , Thyroid Gland/enzymology , Thyroid Gland/metabolism , Thyroid Gland/pathology , Thyroid Neoplasms/genetics , Tumor Suppressor Proteins/metabolism
13.
Brain Dev ; 23(5): 288-97, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11504598

ABSTRACT

Niemann-Pick disease type C (NP-C) disease is a progressive and fatal neurological disorder characterized by accumulation of cholesterol and glycosphingolipids in peripheral tissues and that of glycosphingolipids in the brain. A C57BL/KsJ-npc1(spm) mutant strain is a genetically authentic model of NP-C. This study investigated neuronal cell loss and lipid accumulation in the npc1(spm) mouse brain. Nissl-staining revealed abundant swollen neurons in the neocortex, piriform cortex, hippocampus and basal ganglia at 3-4 wk of age. In addition to loss of the Purkinje cells, we found a conspicuous cell loss in the ventral posterial lateral (VPL) and medial (VPM) nuclei of thalamus, which became apparent after 4-5 wk. Biochemical analyses revealed no increase of cholesterol in the lipid extracts whereas a substantial accumulation of cholesterol was detectable in most of the large neurons by filipin staining in the brain of homozygous mice. In contrast to the diffuse staining pattern in normal brains, the neuropils of the neurons in the brain of homozygous mice were stained in a punctate pattern. The ubiquitous accumulation excludes a direct role of cholesterol in the progressive neuronal loss in the Purkinje cell layer and in the VPL and VPM of the thalamus.


Subject(s)
Mice, Neurologic Mutants/abnormalities , Nerve Degeneration/pathology , Neurons/pathology , Niemann-Pick Diseases/pathology , Ventral Thalamic Nuclei/pathology , Aging/physiology , Animals , Cell Size/genetics , Cholesterol/metabolism , Detergents/pharmacology , Filipin/metabolism , Immunohistochemistry , Liver/metabolism , Liver/pathology , Macrophages/metabolism , Macrophages/pathology , Mice , Mice, Neurologic Mutants/metabolism , Nerve Degeneration/metabolism , Nerve Degeneration/physiopathology , Neurons/metabolism , Niemann-Pick Diseases/metabolism , Niemann-Pick Diseases/physiopathology , Octoxynol , Polyethylene Glycols/pharmacology , Purkinje Cells/metabolism , Purkinje Cells/pathology , Ventral Thalamic Nuclei/metabolism , Ventral Thalamic Nuclei/physiopathology
14.
Cancer Res ; 61(16): 6105-11, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11507060

ABSTRACT

Enhanced activation of Akt occurs in Cowden's disease, an inherited syndrome of follicular thyroid, breast, colon, and skin tumors, via inactivation of its regulatory protein, PTEN. Whereas PTEN inactivation is uncommon in sporadic thyroid cancer, activation of growth factor pathways that signal through Akt is frequently identified. We hypothesized that Akt overactivation could be a common finding in sporadic thyroid cancer and might be important in thyroid cancer biology. We examined thyroid cancer cells lines and benign and malignant thyroid tissue for total Akt activation and isoform-specific Akt expression. In thyroid cancer cells, Akt 1, 2, and 3 proteins were expressed, total Akt was activated by insulin phosphatidylinositol 3'-kinase, and inhibition of phosphatidylinositol 3'-kinase reduced cell viability. In human thyroid tissue, increased levels of phosphorylated total Akt were identified in follicular but not papillary cancers compared with normal tissue. Levels of Akt 1 and 2 proteins and Akt 2 RNA were elevated only in the follicular cancers. In paired samples, Akt 1, 2, 3, and phospho-Akt levels were higher in five of six cancers, including three of three follicular cancers. These data suggest that Akt activation may play a role in the pathogenesis or progression of sporadic thyroid cancer.


Subject(s)
Protein Serine-Threonine Kinases/metabolism , Proto-Oncogene Proteins/metabolism , Thyroid Neoplasms/enzymology , Adenocarcinoma, Follicular/enzymology , Adenocarcinoma, Follicular/genetics , Adenocarcinoma, Follicular/pathology , Carcinoma, Papillary/enzymology , Carcinoma, Papillary/genetics , Carcinoma, Papillary/pathology , Cell Survival/physiology , Enzyme Activation , Gene Expression , Humans , Insulin/pharmacology , Isoenzymes/metabolism , Phosphatidylinositol 3-Kinases/metabolism , Phosphoinositide-3 Kinase Inhibitors , Phosphorylation , Protein Serine-Threonine Kinases/biosynthesis , Protein Serine-Threonine Kinases/genetics , Proto-Oncogene Proteins/biosynthesis , Proto-Oncogene Proteins/genetics , Proto-Oncogene Proteins c-akt , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/physiology , Thyroid Gland/enzymology , Thyroid Neoplasms/genetics , Thyroid Neoplasms/pathology , Thyrotropin/pharmacology , Tumor Cells, Cultured
15.
Jpn J Pharmacol ; 86(3): 329-35, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11488434

ABSTRACT

Neurotropin is a non-protein extract from the dermis of rabbits inoculated with vaccinia virus and has been clinically used as an analgesic in Japan. We present in the current report evidence for its potential therapeutic value against endotoxin shock. Administration of this compound prior to lipopolysaccharide (LPS) challenge resulted in a reversal of a decrease of the mean arterial pressure in rats and also amelioration of lethality in mice. Anti-inducible nitric oxide synthase (iNOS) Western blotting of tissue extracts from LPS-treated mice revealed almost complete suppression of iNOS induction by Neurotropin. The findings in vivo were reproduced in in vitro experiments in which cultured human umbilical vascular endothelial cells were challenged with LPS. Simultaneous treatment of the cells with Neurotropin resulted in complete suppression of iNOS induction and significant reduction of cell death. These results suggested a therapeutic value of Neurotropin in the treatment of endotoxin shock that was linked, at least in part, to suppression of iNOS induction and reduced cell damage in vascular endothelial cells.


Subject(s)
Hypotension/prevention & control , Lipopolysaccharides/toxicity , Nitric Oxide Synthase/biosynthesis , Polysaccharides/pharmacology , Animals , Apoptosis/drug effects , Cells, Cultured , Endothelium, Vascular/cytology , Endothelium, Vascular/drug effects , Enzyme Induction , Humans , Hypotension/chemically induced , Hypotension/enzymology , Lipopolysaccharides/antagonists & inhibitors , Male , Mice , Nitric Oxide Synthase Type II , Rabbits , Rats , Rats, Inbred F344
16.
Diagn Mol Pathol ; 10(2): 123-9, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11385322

ABSTRACT

Fine-needle aspiration (FNA) is a highly sensitive method in the differential diagnosis of thyroid nodules. However, 10% of thyroid FNAs are indeterminate for cancer, and thus additional markers may be useful diagnostically. The authors have demonstrated previously that human telomerase reverse transcriptase (hTERT) gene expression is useful in the distinction of benign lesions from malignant lesions. They therefore wondered whether the detection of hTERT gene expression was feasible using archival slides. To establish an experimental system, ribonucleic acid was extracted from human anaplastic thyroid carcinoma cell line (ARO) in cytologic specimens, and reverse transcription-polymerase chain reaction (RT-PCR) for hTERT expression was performed. RT-PCR analysis for hTERT gene detection was then performed using 58 Diff-Quik-stained archival FNA samples collected retrospectively. RT-PCR for human thyroglobulin (hTg) or beta-actin gene expression served as a positive control. Successful PCR results were obtained from 48 of the 58 cases. All 10 slides in which no RT-PCR products were noted were older than 3 years. hTERT gene expression was demonstrated in FNAs from two of seven cases (29%) of hyperplastic nodule, one of one case (100%) of Hashimoto's thyroiditis, three of eight cases (38%) of follicular adenoma, three of eight cases (38%) of Hürthle cell adenoma, three of four cases (75%) of follicular carcinoma, two of two cases (100%) of Hürthle cell carcinoma, and 11 of 18 cases (61%) of papillary carcinoma. All but one of the available 33 corresponding frozen samples exhibited the same RT-PCR results. This study demonstrates that Diff-Quik-stained thyroid FNA specimens less than 3 years old can be used for the detection of hTERT gene expression by RT-PCR. This test, along with careful cytopathologic examination, may improve our ability to differentiate benign lesions from malignant lesions in indeterminate FNA samples from thyroid nodules.


Subject(s)
RNA , Telomerase/metabolism , Thyroid Neoplasms/enzymology , Thyroid Nodule/enzymology , Actins/genetics , Actins/metabolism , Adenocarcinoma, Follicular/enzymology , Adenocarcinoma, Follicular/genetics , Adenocarcinoma, Follicular/pathology , Adenoma/enzymology , Adenoma/genetics , Adenoma/pathology , Biomarkers, Tumor , Biopsy, Needle , DNA-Binding Proteins , Gene Expression Regulation, Neoplastic , Humans , Hyperplasia , RNA, Messenger/analysis , RNA, Neoplasm/analysis , Reverse Transcriptase Polymerase Chain Reaction , Sensitivity and Specificity , Telomerase/genetics , Thyroglobulin/genetics , Thyroglobulin/metabolism , Thyroid Neoplasms/genetics , Thyroid Neoplasms/pathology , Thyroid Nodule/genetics , Thyroid Nodule/pathology , Thyroiditis, Autoimmune/enzymology , Thyroiditis, Autoimmune/genetics , Thyroiditis, Autoimmune/pathology , Tumor Cells, Cultured
17.
Asian J Androl ; 3(2): 105-8, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11404793

ABSTRACT

AIM: As an attempt to clarify the molecular basis of castration-induced apoptosis, this study was undertaken to demonstrate the expression of caspase-1 in male accessory sex organs of rats. METHODS AND RESULTS: cDNA of rat caspase-1 was cloned by reverse transcription-polymerase chain reaction from the ventral prostates. The open reading frame predicts 402 amino acids, which shows more than 91% and 63% identity to those of mouse and human, respectively. Northern analyses demonstrated the presence of castration-induced up-regulation of the 1.6 kb transcript in the ventral prostate and the seminal vesicles. Finally, the authors demonstrated the caspase-1 transcripts in the epithelia of these tissues by in situ hybridization analyses. CONCLUSION: Castration induces the expression of caspase-1 transcripts in the epithelia of ventral prostate and seminal vesicle. These observations suggest a possible role of caspase-1 in apoptosis in male accessory sex organs.


Subject(s)
Caspase 1/metabolism , Orchiectomy , Prostate/enzymology , Seminal Vesicles/enzymology , Amino Acid Sequence/genetics , Animals , Base Sequence/genetics , Caspase 1/genetics , DNA, Complementary/genetics , Epithelium/enzymology , Male , Molecular Sequence Data , Rats , Rats, Wistar
18.
Thyroid ; 11(4): 339-51, 2001 Apr.
Article in English | MEDLINE | ID: mdl-11349832

ABSTRACT

Thyrotropin (TSH)-initiated cell cycle progression from G1 to S phase in FRTL-5 thyroid cells requires serum, insulin, or insulin-like growth factor 1 (IGF-1) and involves activation of 3-hydroxy-3-methylglutaryl-CoA reductase, geranylgeranylation of RhoA, p27Kip1 degradation, and activation of cyclin-dependent kinase (cdk) 2. In the present report, we show that the serine-threonine kinase Akt is an important mediator of insulin/IGF-1/serum effects on cell cycle progression in FRTL-5 thyroid cells. The phosphoinositol (OH) 3 kinase inhibitors, Wortmannin (WM) and Ly294002 (LY), block the ability of insulin/IGF-1 to reduce p27 expression, to induce expression of cyclins E, D1, and A as well as cdk 2 and 4, and to phosphorylate retinoblastoma protein. They also inhibit insulin/IGF-1-increased DNA synthesis and cell cycle entrance (S+G2/M). Insulin/IGF-1 rapidly induced activation of Aktl in a PI3 kinase-dependent manner, and increased Aktl RNA levels. Most importantly, FRTL-5 cells transfected with a constitutively active form of Aktl have higher basal rates of DNA synthesis and no longer require exogenous insulin/IGF-1 or serum for TSH-induced growth. In sum, Aktl appears to have an important role in insulin/IGF-1 regulation of FRTL-5 thyroid cell growth and cell cycle progression.


Subject(s)
Phosphatidylinositol 3-Kinases/physiology , Protein Serine-Threonine Kinases , Proto-Oncogene Proteins/physiology , Thyroid Gland/cytology , Animals , Cell Cycle , Cell Division , Cell Line , DNA/biosynthesis , Hydroxymethylglutaryl CoA Reductases/genetics , Insulin/pharmacology , Insulin-Like Growth Factor I/pharmacology , Phosphorylation , Proto-Oncogene Proteins c-akt , Rats , Thyrotropin/pharmacology
19.
Mod Rheumatol ; 11(2): 159-61, 2001 Jun.
Article in English | MEDLINE | ID: mdl-24383695

ABSTRACT

Abstract We report a case of a 42-year-old man with antiphospholipid syndrome (APS) with chondritis. He presented with preceding insidious progressive occlusion of the bilateral common iliac arteries extending to the lower two-thirds of the abdominal aorta. Active thrombotic events developed concurrent with the onset of chondritis, and resulted in massive thromboses in multiple organs and renal dysfunction. Both conditions responded well to combined intravenous high-dose methylprednisolone and anticoagulation therapy. The inflammatory component of his disease may have played a major role in the pathogenesis of thrombosis given the concurrent active inflammation from his chondritis.

20.
Int Rev Immunol ; 19(6): 633-64, 2000.
Article in English | MEDLINE | ID: mdl-11129119

ABSTRACT

In this report we summarize evidence to support a model for the development of Graves' disease. The model suggests that Graves' disease is initiated by an insult to the thyrocyte in an individual with a normal immune system. The insult, infectious or otherwise, causes double strand DNA or RNA to enter the cytoplasm of the cell. This causes abnormal expression of major histocompatibility (MHC) class I as a dominant feature, but also aberrant expression of MHC class II, as well as changes in genes or gene products needed for the thyrocyte to become an antigen presenting cell (APC). These include increased expression of proteasome processing proteins (LMP2), transporters of antigen peptides (TAP), invariant chain (Ii), HLA-DM, and the co-stimulatory molecule, B7, as well as STAT and NF-kappaB activation. A critical factor in these changes is the loss of normal negative regulation of MHC class I, class II, and thyrotropin receptor (TSHR) gene expression, which is necessary to maintain self-tolerance during the normal changes in gene expression involved in hormonally-increased growth and function of the cell. Self-tolerance to the TSHR is maintained in normals because there is a population of CD8- cells which normally suppresses a population of CD4+ cells that can interact with the TSHR if thyrocytes become APCs. This is a host self-defense mechanism that we hypothesize leads to autoimmune disease in persons, for example, with a specific viral infection, a genetic predisposition, or even, possibly, a TSHR polymorphism. The model is suggested to be important to explain the development of other autoimmune diseases including systemic lupus or diabetes.


Subject(s)
Graves Disease/immunology , Animals , Antigen-Presenting Cells/immunology , Autoimmune Diseases/genetics , Autoimmune Diseases/immunology , Gene Expression Regulation , Histocompatibility Antigens Class I/immunology , Histocompatibility Antigens Class II/genetics , Histocompatibility Antigens Class II/immunology , Humans , Immune System/immunology , Self Tolerance/immunology , Thymus Gland/cytology , Thyroiditis, Autoimmune/immunology , Thyrotropin/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...